Elanco Animal Health (ELAN) Receivables (2017 - 2026)

Elanco Animal Health has disclosed Receivables across 10 years of filings, most recently posting $1.2 billion for Q1 2026.

• Receivables for Q1 2026 came in at $1.2 billion, up 8.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 8.87% YoY), and the FY2025 annual result was $940.0 million, up 6.09% from the prior year.
• Receivables came in at $1.2 billion for Q1 2026 at Elanco Animal Health, up from $940.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $1.3 billion in Q1 2023 to a low of $886.0 million in Q4 2024.
• The 5-year median for Receivables is $1.1 billion (2024), against an average of $1.1 billion.
• Across the five-year window, Receivables climbed 10.41% in 2023 and fell 20.35% in 2024, its largest moves.
• Elanco Animal Health's Receivables stood at $1.0 billion in 2022, then rose by 0.8% to $1.0 billion in 2023, then decreased by 12.28% to $886.0 million in 2024, then increased by 6.09% to $940.0 million in 2025, then increased by 22.77% to $1.2 billion in 2026.
• The last three Receivables figures came in at $1.2 billion (Q1 2026), $940.0 million (Q4 2025), and $975.0 million (Q3 2025), per Business Quant data.